Streptococcus suis adenosine synthase functions as an effector in evasion of PMN-mediated innate immunity

Journal of Infectious Diseases

Volumn 210, Issue 1, 2014, Pages 35-45

  Liu, Peng ^a   Pian, Yaya ^a   Li, Xueqin ^a   Liu, Renfeng ^a   Xie, Wenlong ^a   Zhang, Chunmao ^a   Zheng, Yuling ^a   Jiang, Yongqiang ^a   Yuan, Yuan ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

A2a receptors; Adenosine synthase; Innate immunity; PMNs; Streptococcus suis serotype 2

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE A2A RECEPTOR; ADENOSINE PHOSPHATE; ADENOSINE SYNTHASE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BIOINFORMATICS; CELL ACTIVITY; CELL SURFACE; CELL WALL; CONTROLLED STUDY; DEGRANULATION; ENZYME ACTIVITY; ENZYME ANALYSIS; GENE INACTIVATION; HUMAN; IMMUNE EVASION; INNATE IMMUNITY; NEUTROPHIL; NONHUMAN; NUCLEIC ACID ANALYSIS; NUCLEIC ACID SYNTHESIS; OXIDATION; PHAGOCYTE; PIGLET; PRIORITY JOURNAL; PROTEIN STRUCTURE; STREPTOCOCCUS SUIS;

ADENOSINE; ANIMALS; BACTERIAL PROTEINS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; NEUTROPHILS; PHAGOCYTOSIS; STREPTOCOCCUS SUIS; SWINE; VIRULENCE FACTORS;

EID: 84900548870     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu050     Document Type: Article

References (45)

1. Clifton-Hadley FA. Streptococcus suis type 2 infections. Br Vet J 1983; 139:1-5.
2. Touil F, Higgins R, Nadeau M. Isolation of Streptococcus suis from diseased pigs in Canada. Vet Microbiol 1988; 17:171-7.
3. Wertheim HFL, Nghia HDT, Taylor W, Schultsz C. Streptococcus suis: an emerging human pathogen. Clin Infect Dis 2009; 48:617-25.
4. Lun ZR, Wang QP, Chen XG, Li AX, Zhu XQ. Streptococcus suis: an emerging zoonotic pathogen. Lancet Infect Dis 2007; 7:201-9.
5. Wangkaew S, Chaiwarith R, Tharavichitkul P, Supparatpinyo K. Streptococcus suis infection: a series of 41 cases from Chiang Mai University Hospital. J Infect 2006; 52:455-60.
6. Yu HJ, Jing HQ, Chen ZH, et al. Human Streptococcus suis outbreak, Sichuan, China. Emerg Infect Dis 2006; 12:914-20.
7. Tang J, Wang C, Feng Y, et al. Streptococcal toxic shock syndrome caused by Streptococcus suis serotype 2. PLoS Med 2006; 3:668-76.
8. Hasko G. Adenosine A2A receptor inactivation increases survival in polymicrobial sepsis. Inflamm Res 2007; 56:S87-S87.
9. Thiel M, Caldwell CC, Sitkovsky MV. The critical role of adenosine A (2A) receptors in downregulation of inflammation and immunity in the pathogenesis of infectious diseases. Microbes Infect 2003; 5:515-26.
10. Hasko G, Pacher P. A(2A) receptors in inflammation and injury: lessons learned from transgenic animals. J Leukoc Biol 2008; 83:447-55.
11. Tucker AL, Linden J. Cloned receptors and cardiovascular responses to adenosine. Cardiovasc Res 1993; 27:62-7.
12. Hasko G, Cronstein BN. Adenosine: an endogenous regulator of innate immunity. Trends Immunol 2004; 25:33-9.
13. Hasko G, Deitch EA, Szabo C, Nemeth ZH, Vizi ES. Adenosine: a potential mediator of immunosuppression in multiple organ failure. Curr Opin Pharmacol 2002; 2:440-4.
14. Ohta A, Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 2001; 414:916-20.
15. Fredholm BB, Ijzerman AP, Jacobson KA, Klotz KN, Linden J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 2001; 53:527-52.
16. Sullivan GW, Linden J. Role of A(2A) adenosine receptors in inflammation. Drug Develop Res 1998; 45:103-12.
17. Link AA, Kino T, Worth JA, et al. Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes. J Immunol 2000; 164:436-42.
18. Belikoff B, Hatfield S, Sitkovsky M, Remick DG. Adenosine negative feedback on a2a adenosine receptors mediates hyporesponsiveness in chronically septic mice. Shock 2011; 35:382-7.
19. Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, Halbwachs- Mecarelli L. Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest 2000; 80:617-53.
20. Thibault N, Burelout C, Harbour D, Borgeat P, Naccache PH, Bourgoin SG. Occupancy of adenosine A2a receptors promotes fMLP-induced cyclic AMP accumulation in human neutrophils: impact on phospholipase D activity and recruitment of small GTPases to membranes. J Leukoc Biol 2002; 71:367-77.
21. Rose FR, Hirschhorn R, Weissmann G, Cronstein BN. Adenosine promotes neutrophil chemotaxis. J Exp Med 1988; 167:1186-94.
22. Sullivan GW, Linden J, Buster BL, Scheld WM. Neutrophil A(2A) adenosine receptor inhibits inflammation in a rat model of meningitis: synergy with the type IV phosphodiesterase inhibitor, rolipram. J Infect Dis 1999; 180:1550-60.
23. Cronstein BN, Levin RI, Philips M, Hirschhorn R, Abramson SB, Weissmann G. Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors. J Immunol 1992; 148:2201-6.
24. Felsch A, Stocker K, Borchard U. Phorbol ester-stimulated adherence of neutrophils to endothelial-cells is reduced by adenosine A(2) receptor agonists. J Immunol 1995; 155:333-8.
25. Sullivan GW, Rieger JM, Scheld WM, Macdonald TL, Linden J. Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists. Br J Pharmacol 2001; 132:1017-26.
26. Cronstein BN, Kramer SB, Rosenstein ED, Korchak HM,Weissmann G, Hirschhorn R. Occupancy of adenosine receptors raises cyclic AMP alone and in synergy with occupancy of chemoattractant receptors and inhibits membrane depolarization. Biochem J 1988; 252:709-15.
27. Fredholm BB, Zhang Y, vanderPloeg I. AdenosineA(2A) receptors mediate the inhibitory effect of adenosine on formyl-Met-Leu-Phe-stimulated respiratory burst in neutrophil leucocytes. Naunyn Schmiedebergs Arch Pharmacol 1996; 354:262-7.
28. Sullivan GW, Carper HT, Mandell GL. The specific type-iv phosphodiesterase inhibitor rolipram combined with adenosine reduces tumor necrosis factor-alpha-primed neutrophil oxidative activity. Int J Immunopharmacol 1995; 17:793-803.
29. Richter J. Effect of adenosine analogues and cAMP-raising agents on TNF-, GM-CSF-, and chemotactic peptide-induced degranulation in single adherent neutrophils. J Leukoc Biol 1992; 51:270-5.
30. Visser SS, Theron AJ, Ramafi G, Ker JA, Anderson R. Apparent involvement of the A(2A) subtype adenosine receptor in the anti-inflammatory interactions of CGS 21680, cyclopentyladenosine, and IB-MECA with human neutrophils. Biochem Pharmacol 2000; 60:993-9.
31. Hwang TL, Yeh SH, Leu YL, Chern CY, Hsu HC. Inhibition of superoxide anion and elastase release in human neutrophils by 3′-isopropoxychalcone via a cAMP-dependent pathway. Br J Pharmacol 2006; 148:78-87.
32. Pian Y, Gan S,Wang S, et al. Fhb, a novel factor H-binding surface protein, contributes to the antiphagocytic ability and virulence of Streptococcus suis. Infect Immun 2012; 80:2402-13.
33. Takamatsu D, Osaki M, Sekizaki T. Thermosensitive suicide vectors for gene replacement in Streptococcus suis. Plasmid 2001; 46:140-8.
34. de Greeff A, Buys H, Verhaar R, Dijkstra J, van Alphen L, Smith HE. Contribution of fibronectin-binding protein to pathogenesis of Streptococcus suis serotype 2. Infect Immun 2002; 70:1319-25.
35. Yamaguchi M, Terao Y, Ogawa T, Takahashi T, Hamada S, Kawabata S. Role of Streptococcus sanguinis sortase A in bacterial colonization. Microbes Infect 2006; 8:2791-6.
36. Geng HR, Zhu L, Yuan Y, et al. Identification and characterization of novel immunogenic proteins of Streptococcus suis serotype 2. J Proteome Res 2008; 7:4132-42.
37. Knofel T, Strater N. Mechanism of hydrolysis of phosphate esters by the dimetal center of 5 '-nucleotidase based on crystal structures. J Mol Biol 2001; 309:239-54.
38. Thammavongsa V, Kern JW, Missiakas DM, Schneewind O. Staphylococcus aureus synthesizes adenosine to escape host immune responses. J Exp Med 2009; 206:2417-27.
39. Galeotti CL, Bove E, Pezzicoli A, et al. Surface interactome in Streptococcus pyogenes. Mol Cell Proteomics 2012; 11:M111015206.
40. Knofel T, Strater N. X-ray structure of the Escherichia coli periplasmic 5 '-nucleotidase containing a dimetal catalytic site. Nat Struct Biol 1999; 6:448-53.
41. Segura M. Streptococcus suis: an emerging human threat. J Infect Dis 2009; 199:4-6.
42. Foster TJ. Immune evasion by Staphylococci. Nat Rev Microbiol 2005; 3:948-58.
43. Peschel A, Sahl HG. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat Rev Microbiol 2006; 4:529-36.
44. Lecours M-P, Gottschalk M, Houde M, Lemire P, Fittipaldi N, Segura M. Critical role for Streptococcus suis cell wall modifications and suilysin in resistance to complement-dependent killing by dendritic cells. J Infect Dis 2011; 204:919-29.
45. Belikoff BG, Hatfield S, Georgiev P, et al. A2B adenosine receptor blockade enhances macrophage-mediated bacterial phagocytosis and improves polymicrobial sepsis survival in mice. J Immunol 2011; 186:2444-53.